查詢結果分析
相關文獻
- HPLC Determination of 9,10-Anthraquinone-2-Carboxylic Acid in Serum and Its Application to Pharmacokinetic Study
- Absorption and Disposition Kinetics of Trimethoprim Following Intramuscular Injection in Rabbits
- Relative Bioavailability Study of Cefuroxime Axetil Tablets
- Pharmacokinetics of Benzbromarone in Normal Chinese Males
- Pharmacokinetics and Bioequivalent Study of Generic Fluoxetine Capsules Preparation
- Relative Bioavailability of Salmon Calcitonin Given Intramuscularly
- Absorption Study with a Dissolution Independent Drug-Acetaminophen
- Pharmacokinetics of Anti-SARS-CoV Agent Niclosamide and Its Analogs in Rats
- 選擇性血清素再吸收抑制劑
- Fluvoxamine對Clozapine藥物動力學之影響
頁籤選單縮合
題 名 | HPLC Determination of 9,10-Anthraquinone-2-Carboxylic Acid in Serum and Its Application to Pharmacokinetic Study=高效液相層析法檢測血清中9,10-蒽醌酮-2-羧酸濃度及其在藥物動力學研究之應用 |
---|---|
作 者 | 鄭信宏; 林文川; 黃太鴻; 郭盛助; 蔡尚元; | 書刊名 | 藥物食品分析 |
卷 期 | 7:3 1999.09[民88.09] |
頁 次 | 頁199-205 |
分類號 | 418.1 |
關鍵詞 | 9,10-蒽醌酮-2-羧酸; 藥物動力學; 生體可用率; 高效液相層析法; 9,10-anthraquinone-2-carboxylic acid; Pharmacokinetics; Bioavailability; High performance liquid chromatography; HPLC; |
語 文 | 英文(English) |
中文摘要 | 本研究發展出一簡單、高感度和精確之高效液相層析法,用以檢測家兔血清中9,10- 蔥□酮-2-羧酸(AQCA)濃度。本分析法以Lichrosher 100RP-18為層析管柱,0.4%磷酸:乙氰 (7:3)/甲醇=45:55為移動相,流速為1.2mL/min,紫外光檢測器之檢測波長為256nm,甲基 苯甲酸為內標準品。檢品經簡單處理後,注入管柱分析。最低檢測值為0.6μg/mL,於0.6- 18μg/mL濃度間具有良好的線性檢量關係、確效試驗顯示,精密度佳(變異係數少於2%), 回收率為96.98%。 繼以此分析法應用於藥品動力分析研究之探討。十八隻家兔分成三組,取不同劑型之 AQCA,以相同的單一劑量(10 mg/kg),分別以血管注射、口服和直腸投藥,檢測各組各時 段血清中的AQCA濃度,經Winnolin軟體處理資料,並以ANOVA試驗(α=0.05)評定各組重 要的藥品動力參數之異同。注射投藥時,半衰期(t□)、血清濃度一時間曲線下面積(AUC)分 別為4.43±0.13hrs和141.79±7.84μg*hr/mL。口服投藥的參數數據為血清中尖峰濃度(T □)=7.17±0.41hrs;t□=15.3±1.86hrs;平均滯留時間(MRT)=20.02±2.07hrs;AUC=107.53 ±4.50μg*hr/mL,顯示口服途徑的藥品吸收速率慢、滯留時間長、吸收總量低。直腸投藥 的參數數據為T□=1.58±0.20hrs;t□=5.67±0.82hrs;AUC=121.18±6.19μg*hr/mL,依數 據比較,藥物吸收速率及吸收總量均比前者好。另者,在本劑量下,口服和直腸投藥的絕對 生體可用率分別為0.876和0.872。這些參數上的差異可能是AQCA於不同的劑型與投藥部 位、有不同的溶離性質所致。 |
英文摘要 | A simple and sensitive high-performance liquid chromatographic (HPLC) method involving UV detection was developed for the determination of 9,10- anthraquinone-2-carboxylic acid (AQCA) in rabbit serum. A reverse-phase column (Lichrosher □100RP-18) was eluted with a mobile phase of 0.4% phosphoric acid: acetonitrile (7:3) / methanol = 45 : 55 at a flow rate of 1.2 mL/min. The UV absorbance was monitored at 256 nm. After a simple clean-up procedure, the limit of quantitation achieved was 0.6 μg/mL and the standard curve was found to be linear over the serum concentration of 0.6-18μg/mL. The intra-assay and inter-assay coefficient of variance in serum was less than 2%, and the recover v was 96.98%. The established HPLC method was applied to the study of pharmacokinetics and bioavailability of 9,10-anthraquinone-2-carboxylic acid (AQCA). Eighteen healthy rabbits were divided into three groups and given intravenous (i.v.), oral and rectal administrations of different AQCA preparations with a single dose of 10 mg/kg. Blood samples were collected and AQCA concentrations in serum were analyzed. The results were performed with Winnolin programs and the ANOVA test (α=0.05) was used to compare the pharmacokinetic parameters of AQCA in the three regimens. For the i.v. route, the t□ and AUC were 4.43±0.13 hrs and 141.79±7.84 μg*hr/mL, respectively. Parameters for the oral route were : T□=7.17±0.41 hrs ; t□=15.32±1.86 hrs; MRT=20.02±2.07 hrs and AUC=107.53±4.50 μg*hr/mL. The oral route indicated a slower absorption rate, a longer residence time and a lower extent of the AQCA absorption. For the rectal route, T□ occurred at 1.58±0.20 hrs, the t□ was 5.67±0.82 hrs and the AUC was 121.18±6.19 μg*hr/mL. The results indicated that the rate and extent of AQCA rectal absorption were better compared to those of the oral route. At this dose, the absolute bioavailabilities of AQCA were 0.876 and 0.872 for oral and rectal administrations, respectively. The differences of these pharmacokinetic parameters might be due to the physicochemical properties of AQCA in different conditions. rent conditions. |
本系統中英文摘要資訊取自各篇刊載內容。